SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,514,520 | +43668.5% | 1,094,000 | 0.0% | 1.20% | -49.7% |
| Q2 2023 | $51,440 | +12.1% | 1,094,000 | 0.0% | 2.39% | +5.8% |
| Q1 2023 | $45,904 | -99.9% | 1,094,000 | 0.0% | 2.26% | +2.5% |
| Q4 2022 | $41,725,160 | -2.6% | 1,094,000 | 0.0% | 2.20% | -8.7% |
| Q3 2022 | $42,841,000 | +21.2% | 1,094,000 | 0.0% | 2.41% | +7.6% |
| Q2 2022 | $35,336,000 | -2.4% | 1,094,000 | 0.0% | 2.24% | +20.3% |
| Q1 2022 | $36,211,000 | -22.2% | 1,094,000 | 0.0% | 1.86% | +2.9% |
| Q4 2021 | $46,539,000 | -4.0% | 1,094,000 | 0.0% | 1.81% | +6.8% |
| Q3 2021 | $48,475,000 | -22.0% | 1,094,000 | 0.0% | 1.69% | -22.8% |
| Q2 2021 | $62,150,000 | -24.1% | 1,094,000 | 0.0% | 2.19% | -21.0% |
| Q1 2021 | $81,886,000 | -13.5% | 1,094,000 | 0.0% | 2.78% | -8.7% |
| Q4 2020 | $94,642,000 | +41.5% | 1,094,000 | 0.0% | 3.04% | +31.6% |
| Q3 2020 | $66,865,000 | +47.0% | 1,094,000 | 0.0% | 2.31% | +15.6% |
| Q2 2020 | $45,489,000 | +3.4% | 1,094,000 | -28.6% | 2.00% | -33.3% |
| Q1 2020 | $44,014,000 | +74.2% | 1,532,510 | +337.9% | 3.00% | +109.9% |
| Q4 2019 | $25,267,000 | – | 350,000 | – | 1.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |